South Korea has delayed the implementation of a crypto tax until 2027, reaffirming its pro-crypto stance amid political uncertainty following President Yoon Suk-yeol's impeachment. The government aims to develop a comprehensive regulatory framework while monitoring global trends, particularly U.S. policies under President-elect Donald Trump. Despite the turmoil, trading activity remains strong on major exchanges as investors seek cryptocurrencies as a hedge against the weakening Korean Won.
The Global Fermented Beverages market, valued at 860 billion USD in 2024, is projected to reach 1.3 trillion USD by 2032, growing at a CAGR of 6.4%. The market analysis covers major regions including North America, Europe, and Asia-Pacific, with customization options available for specific countries and applications. Key players include Apple, Microsoft, and Nestlé, with insights into market dynamics, competitive landscape, and growth drivers such as lifestyle changes and technological advancements in fermentation.
In 2024, losses from crypto scams and hacks surged by 21%, totaling $2.2 billion across 303 incidents, with centralized services and private key compromises being primary targets. Notable exploits included the $305 million DMM hack and a $235 million breach of WazirX. As AI-driven attacks rise, experts stress the need for enhanced security measures and regulatory oversight to combat evolving threats.
South Korean prosecutors are seeking a six-month prison sentence for lawmaker Kim Nam-kuk, who allegedly failed to report his cryptocurrency holdings, claiming only 1.2 billion won in assets while actually possessing 9.9 billion won. Kim, who left the Democratic Party amid these allegations, is accused of obstructing the National Assembly Ethics Committee's review of his assets. His trial is occurring against a backdrop of political turmoil following President Yoon Suk Yeol's martial law declaration and subsequent impeachment by the National Assembly.
The global gene therapy market, valued at $7.54 billion in 2022, is projected to reach $41.38 billion by 2031, driven by increased R&D, favorable regulations, and collaborations between pharmaceutical companies and academic institutions. North America leads the market, with significant advancements in biotechnology and numerous clinical trials. Recent developments include Novartis's acquisition of a gene therapy candidate from Avrobio and Bristol-Myers Squibb's expansion of its cell therapy manufacturing network.
Asian stocks are showing mixed results as investors await the Federal Reserve's final rate decision of the year. In related news, Japanese automakers Nissan and Honda have confirmed ongoing discussions aimed at closer collaboration.
Asian stocks mostly rose ahead of the Federal Reserve's final rate decision of the year, with Japan's Nikkei 225 slipping 0.2% despite a 3.8% increase in exports. Trading in Nissan shares was suspended after a 22% surge amid merger talks with Honda, while the Hang Seng and Shanghai Composite gained 0.6% and 0.7%, respectively. The S&P 500 is on track for a nearly 27% annual gain, as strong retail sales data raises questions about the need for further rate cuts.
World stocks showed mixed performance ahead of the Federal Reserve's rate decision, with European markets opening higher. Nissan shares surged 23.7% amid collaboration talks with Honda, while Japan's Nikkei 225 fell 0.7% following export data. The S&P 500 is poised for a strong year, up nearly 27%, as the Fed is expected to announce a third rate cut amid persistent inflation concerns.
World stocks are mixed as markets await the Federal Reserve's rate decision. European indices opened higher, while Japan's Nikkei 225 fell 0.7%. Nissan shares surged 23.7% amid collaboration talks with Honda, while U.S. retail sales exceeded expectations, hinting at a resilient economy.
Asian stocks mostly rose ahead of the Federal Reserve's rate decision, with Japan's Nikkei 225 slipping 0.2% despite a 3.8% increase in exports. Nissan's shares surged 22% amid merger talks with Honda, while the Hang Seng and Shanghai Composite gained 0.6% and 0.7%, respectively. The Fed is expected to announce a rate cut, but strong economic data may lead to a pause in January.
Seems like the connection with the server has been lost. It can be due to poor or broken network. Please hang on while we're trying to reconnect...
Oh snap! Failed to reconnect with the server. This is typically caused by a longer network outage, or if the server has been taken down. You can try to reconnect, but if that does not work, you need to reload the page.
Oh man! The server rejected the attempt to reconnect. The only option now is to reload the page, but be prepared that it won't work, since this is typically caused by a failure on the server.